Meridian Financial Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-15,521
Closed -$930K 102
2024
Q2
$930K Buy
+15,521
New +$971K 0.55% 46
2023
Q3
Sell
-14,338
Closed -$1.07M 54
2023
Q2
$1.07M Buy
+14,338
New +$1.02M 0.64% 41
2022
Q3
Sell
-12,549
Closed -$1.2M 51
2022
Q2
$1.2M Buy
+12,549
New +$1.22M 0.82% 32
2022
Q1
Sell
-12,275
Closed -$1.27M 49
2021
Q4
$1.27M Buy
12,275
+510
+4% +$47.1K 0.86% 28
2021
Q3
$978K Buy
11,765
+13
+0.1% +$1.09K 0.66% 35
2021
Q2
$961K Buy
11,752
+418
+4% +$34.2K 0.66% 35
2021
Q1
$860K Buy
11,334
+343
+3% +$25K 0.65% 33
2020
Q4
$827K Buy
10,991
+91
+0.8% +$5.92K 0.64% 33
2020
Q3
$649K Buy
10,900
+1,016
+10% +$63.2K 0.55% 34
2020
Q2
$630K Buy
9,884
+541
+6% +$34.1K 0.57% 34
2020
Q1
$592K Buy
9,343
+100
+1% +$6.68K 0.64% 27
2019
Q4
$672K Buy
9,243
+407
+5% +$28.6K 0.67% 25
2019
Q3
$543K Buy
8,836
+257
+3% +$15.2K 0.61% 31
2019
Q2
$477K Buy
8,579
+218
+3% +$11.7K 0.53% 35
2019
Q1
$439K Buy
8,361
+815
+11% +$50.3K 0.5% 37
2018
Q4
$494K Buy
+7,546
New +$563K 0.67% 25

Other funds holding CVS

Meridian Financial Partners's CVS Position: Q3 2024 in Review

Meridian Financial Partners sold out of CVS Health (CVS) in Q3 2024, closing a stake of 15,521 shares — an estimated $930K sold.

Meridian Financial Partners first reported a position in CVS in Q4 2018 and held it in 16 quarters. The position peaked at $1.27M in Q4 2021. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Meridian Financial Partners reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • Meridian Financial Partners sold 15,521 CVS Health shares in Q3 2024, an estimated $930K.
  • Meridian Financial Partners first reported a position in CVS Health in Q4 2018 and held it in 16 quarters.
  • Meridian Financial Partners's CVS Health position peaked at $1.27M in Q4 2021.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Meridian Financial Partners's 13F filing for Q3 2024, filed 17 Oct 2024.